LivingGLP1
Study S002734

Management of the Patient With Heart Failure and Diabetes: May Insulin be a Problem? A Pilot Randomized Clinical Study (Insulin-HF)

Registration

Registration
NCT03665350
Acronym
Insulin-HF
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
SINGLE
Status
TERMINATED
Enrollment
10
Start
2018-11-08
Primary completion
2019-09-18
Lead sponsor
Mario Negri Institute for Pharmacological Research
Conditions
Heart Failure; Diabetes Mellitus, Type 2
Interventions
DRUG:Insulin
Results posted
FALSE
Individual participant data sharing
UNDECIDED
Secondary identifiers
EUDRACT_NUMBER:2018-001057-26; NIH:2018

Registered primary outcomes

  • Change in blood glucose variability [baseline to 12 months.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.